First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung CancerLeora Horn, Stephen V. Liu, Martin Reck et al.|New England Journal of Medicine|2018Cited by 3.5k
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trialRobert Pirker, U. Gatzemeier, Jose R. Pereira et al.|The Lancet|2009Cited by 1.4k
Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study GroupFrank V. Fossella, Chandra P. Belani, Jose R. Pereira et al.|Journal of Clinical Oncology|2003Cited by 943
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation TrialU. Gatzemeier, Joachim von Pawel, A Płużańska et al.|Journal of Clinical Oncology|2007Cited by 879
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung CancerRamaswamy Govindan, Martin Reck, Aleksandra Szczęsna et al.|Journal of Clinical Oncology|2017Cited by 380